“Research for a life without cancer" is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts – whether in research, administration or infrastructure. This is what makes our daily work so meaningful and exciting.

The National Center for Tumor Diseases (NCT) is a long-term cooperation between the German Cancer Research Center (DKFZ), excellent partners in university medicine and other research institutions at six locations in Germany. The goal of the NCT is to bring promising results from cancer research into clinical application quickly and safely. This approach is intended to provide cancer patients with nationwide access to innovative treatment options.

One of the six NCT sites is the NCT Dresden (NCT/UCC), which is a collaboration between the DKFZ, the University Hospital Carl Gustav Carus Dresden (UCC), the Carl Gustav Carus Medical Faculty of the TU Dresden and the Helmholtz Center Dresden-Rossendorf (HZDR).

Starting in January 2026, we are seeking for the Division of Translational Imaging in Oncology at the NCT site in Dresden a Postdoctoral Scientist.

Reference number: 2025-0195

Our division uses imaging to optimize new therapies and investigates new radio-tracers. In close cooperation with the Helmholtz Center Dresden-Rossendorf, preclinical projects for modeling theranostic applications with alpha-emitting nuclides for breast cancer are planned. Therefore, we are seeking a motivated postdoctoral researcher with experience in animal models for tumor therapy.

• Correlation of positron emission tomography imaging with histological analyses in rodent tumor models for breast cancer
• Conducting cell binding studies in vitro and biodistribution studies in vivo with established imaging tracers to quantify molecular targeting
• Using carrier molecules (radioligands) coupled to alpha- and beta-emitting radionuclides to investigate therapeutic effects in these models
• Compliance with radiation protection and animal welfare regulations and communication with the respective authorities, if necessary, for obtaining relevant approvals

• Master's degree and PhD in biology, biochemistry or a related field
• Experience with small animal handling and in vivo experiments
• Experience with in vitro experiments and cell culturing
• Enthusiastic and motivated team player
• Good communicative skills as well as fluency in English

Interested candidates should submit one PDF file with a CV, cover letter, certificates, and letters of recommendation via our online application portal.

• Excellent framework conditions: state-of-the-art equipment and oppor­tunities for inter­national networking at the highest level
• Remuneration according to TV-L incl. occupational pension plan and capital-forming payments
• 30 days of vacation per year
• Flexible working hours
• Possibility of part-time work
• Family-friendly working environ­ment
• Sustainable travel to work: subsidized Germany job ticket
• Our Corporate Health Manage­ment Program offers a holistic approach to your well-being
• Develop your full potential: access to the DKFZ International Postdoc Program and DKFZ Career Service with targeted offers for your personal development to further develop your talents

Prof. Dr. Matthias Miederer
Phone: +49 351 458-17256

The position is initially limited to 2 years with the possibility of prolongation. 

Application Deadline: 29.08.2025

Are you interested?
Then become part of the DKFZ and join us in contributing to a life without cancer!

We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.

Notice: We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.

Deutsches Krebsforschungszentrum | Im Neuenheimer Feld 280 | 69120 Heidelberg | www.dkfz.de